Small Pharma Inc.
OTC: DMTTF0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- Other OTC
- Sector
- Healthcare
- Industry
- Biotechnology
- CEO
- George Tziras
- Headquarters
- London, United Kingdom
- IPO year
- 2021
- Market cap
- $37.5M
- Website
- https://www.smallpharma.com
Loading DMTTF…
Loading profile data…Frequently asked questions about DMTTF
What does Small Pharma Inc. (DMTTF) do?
Small Pharma Inc. is a biotechnology firm focused on developing fast-acting psychedelic therapies, coupled with supportive psychological care, to address mental health conditions. Its flagship clinical initiative centers on N,N-dimethyltryptamine (DMT) assisted therapy designed to combat major depressive disorder. Specifically, its compound SPL0...
Where does DMTTF trade?
Small Pharma Inc. (DMTTF) trades on the Other OTC.
What sector is DMTTF in?
Small Pharma Inc. (DMTTF) operates in the Healthcare sector, specifically in the Biotechnology industry.
Who is the CEO of Small Pharma Inc.?
George Tziras is the chief executive officer of Small Pharma Inc. (DMTTF).
Where is Small Pharma Inc. headquartered?
Small Pharma Inc. is headquartered in United Kingdom.
Does DMTTF pay a dividend?
Small Pharma Inc. (DMTTF) does not currently pay a regular dividend. Check the dividends tab for any historical or special distributions.
When did DMTTF go public?
Small Pharma Inc. (DMTTF) completed its initial public offering in 2021.